Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome

Hidehiko Saito, Lawrence T. Goodnough, Sudesh P Makker, Ronald J. Kallen

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Acquired deficiencies of functional Hageman factor (factor XII) and prekallikrein, proteins involved in the plasma kinin-generating system, have been previously reported in the nephrotic syndrome. The basis for these changes, however, is not fully understood. We have examined the levels of Hageman factor and prekallikrein by functional and radioimmunoassays in plasmas and urines of 11 patients with the nephrotic syndrome. All 11 patients had decreased titers of plasma Hageman factor activity (mean ± standard deviation (SD), 0.29 ± 0.15 U/ml), but essentially normal titers of immunoreactive Hageman factor (0.88 ± 0.23 U/ml). The ratio of immunoreactive Hageman factor to functional Hageman factor (2.63 ± 0.86) was significantly higher than that in nine control patients (1.08 ± 0.17). Since no circulating anticoagulants against Hageman factor were detected, these data suggest the presence of nonfunctional (altered) Hageman factor in plasmas of patients with the nephrotic syndrome. Urinary excretion of Hageman factor was present in six patients but did not appear to account for the reduced plasma Hageman factor activity. Urinary Hageman factor in one patient had the same size as plasma Hageman factor as assessed by gel filtration and sucrose density gradient centrifugation. The titers of plasma prekallikrein were within the normal range. These studies indicate urinary excretion of Hageman factor and alterations in the functional sites of plasma Hageman factor molecules in the nephrotic syndrome. Whether these changes are related to the pathogenesis of the nephrotic syndrome remains to be determined.

Original languageEnglish (US)
Pages (from-to)531-534
Number of pages4
JournalThe American journal of medicine
Volume70
Issue number3
DOIs
StatePublished - 1981
Externally publishedYes

Fingerprint

Factor XII
Nephrotic Syndrome
Prekallikrein
Factor XII Deficiency
Kinins
Density Gradient Centrifugation

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome. / Saito, Hidehiko; Goodnough, Lawrence T.; Makker, Sudesh P; Kallen, Ronald J.

In: The American journal of medicine, Vol. 70, No. 3, 1981, p. 531-534.

Research output: Contribution to journalArticle

@article{a917455e5b9c4997a764ea671989c321,
title = "Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome",
abstract = "Acquired deficiencies of functional Hageman factor (factor XII) and prekallikrein, proteins involved in the plasma kinin-generating system, have been previously reported in the nephrotic syndrome. The basis for these changes, however, is not fully understood. We have examined the levels of Hageman factor and prekallikrein by functional and radioimmunoassays in plasmas and urines of 11 patients with the nephrotic syndrome. All 11 patients had decreased titers of plasma Hageman factor activity (mean ± standard deviation (SD), 0.29 ± 0.15 U/ml), but essentially normal titers of immunoreactive Hageman factor (0.88 ± 0.23 U/ml). The ratio of immunoreactive Hageman factor to functional Hageman factor (2.63 ± 0.86) was significantly higher than that in nine control patients (1.08 ± 0.17). Since no circulating anticoagulants against Hageman factor were detected, these data suggest the presence of nonfunctional (altered) Hageman factor in plasmas of patients with the nephrotic syndrome. Urinary excretion of Hageman factor was present in six patients but did not appear to account for the reduced plasma Hageman factor activity. Urinary Hageman factor in one patient had the same size as plasma Hageman factor as assessed by gel filtration and sucrose density gradient centrifugation. The titers of plasma prekallikrein were within the normal range. These studies indicate urinary excretion of Hageman factor and alterations in the functional sites of plasma Hageman factor molecules in the nephrotic syndrome. Whether these changes are related to the pathogenesis of the nephrotic syndrome remains to be determined.",
author = "Hidehiko Saito and Goodnough, {Lawrence T.} and Makker, {Sudesh P} and Kallen, {Ronald J.}",
year = "1981",
doi = "10.1016/0002-9343(81)90575-1",
language = "English (US)",
volume = "70",
pages = "531--534",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Urinary excretion of Hageman factor (factor XII) and the presence of nonfunctional Hageman factor in the nephrotic syndrome

AU - Saito, Hidehiko

AU - Goodnough, Lawrence T.

AU - Makker, Sudesh P

AU - Kallen, Ronald J.

PY - 1981

Y1 - 1981

N2 - Acquired deficiencies of functional Hageman factor (factor XII) and prekallikrein, proteins involved in the plasma kinin-generating system, have been previously reported in the nephrotic syndrome. The basis for these changes, however, is not fully understood. We have examined the levels of Hageman factor and prekallikrein by functional and radioimmunoassays in plasmas and urines of 11 patients with the nephrotic syndrome. All 11 patients had decreased titers of plasma Hageman factor activity (mean ± standard deviation (SD), 0.29 ± 0.15 U/ml), but essentially normal titers of immunoreactive Hageman factor (0.88 ± 0.23 U/ml). The ratio of immunoreactive Hageman factor to functional Hageman factor (2.63 ± 0.86) was significantly higher than that in nine control patients (1.08 ± 0.17). Since no circulating anticoagulants against Hageman factor were detected, these data suggest the presence of nonfunctional (altered) Hageman factor in plasmas of patients with the nephrotic syndrome. Urinary excretion of Hageman factor was present in six patients but did not appear to account for the reduced plasma Hageman factor activity. Urinary Hageman factor in one patient had the same size as plasma Hageman factor as assessed by gel filtration and sucrose density gradient centrifugation. The titers of plasma prekallikrein were within the normal range. These studies indicate urinary excretion of Hageman factor and alterations in the functional sites of plasma Hageman factor molecules in the nephrotic syndrome. Whether these changes are related to the pathogenesis of the nephrotic syndrome remains to be determined.

AB - Acquired deficiencies of functional Hageman factor (factor XII) and prekallikrein, proteins involved in the plasma kinin-generating system, have been previously reported in the nephrotic syndrome. The basis for these changes, however, is not fully understood. We have examined the levels of Hageman factor and prekallikrein by functional and radioimmunoassays in plasmas and urines of 11 patients with the nephrotic syndrome. All 11 patients had decreased titers of plasma Hageman factor activity (mean ± standard deviation (SD), 0.29 ± 0.15 U/ml), but essentially normal titers of immunoreactive Hageman factor (0.88 ± 0.23 U/ml). The ratio of immunoreactive Hageman factor to functional Hageman factor (2.63 ± 0.86) was significantly higher than that in nine control patients (1.08 ± 0.17). Since no circulating anticoagulants against Hageman factor were detected, these data suggest the presence of nonfunctional (altered) Hageman factor in plasmas of patients with the nephrotic syndrome. Urinary excretion of Hageman factor was present in six patients but did not appear to account for the reduced plasma Hageman factor activity. Urinary Hageman factor in one patient had the same size as plasma Hageman factor as assessed by gel filtration and sucrose density gradient centrifugation. The titers of plasma prekallikrein were within the normal range. These studies indicate urinary excretion of Hageman factor and alterations in the functional sites of plasma Hageman factor molecules in the nephrotic syndrome. Whether these changes are related to the pathogenesis of the nephrotic syndrome remains to be determined.

UR - http://www.scopus.com/inward/record.url?scp=0019475545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019475545&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(81)90575-1

DO - 10.1016/0002-9343(81)90575-1

M3 - Article

VL - 70

SP - 531

EP - 534

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 3

ER -